top of page

Basel Investor Forum: Art Basel edition 2025

Day 1: Investment Trends and Exit strategies (17 June 2025)

Capital is flowing into sectors positioned at the edge of what’s technically possible — AI, quantum, synthetic biology, 3D printing, next-gen materials, climate tech, and next-gen healthcare. How can investors adapt their investment strategies? The global investment landscape is undergoing a profound shift — while family offices, VCs and other investors are facing increasing complexity in aligning legacy investment strategies with demands for sustainability, cross-border partnerships, and impact-driven outcomes. Successfully bridging the expectations gap between investors and startups, and building scalable exit pathways, is now critical.

​

Day 1:

Emerging Trends & Investment Strategies

Focus:  Exploring the latest investment trends, disruptive sectors, and exit strategies. Comparing global trends vs. regional needs and challenges.

  • Block 1: The Future of Venture & Family Office Investments. Global trends and regional needs.

  • Block 2: Scaling Biotech: Building Strategic Partnerships for Global Growth.                                                                                 Industry role as major partner for Investor Strategies & Scaling Healthcare

​

Block 1 was focused on understanding global investment trends and sector-specific signals, how to equip investors to sharpen their perspective on where — and how — to deploy into tomorrow’s foundational technologies and adapt to the global changes. We dived into the Future of Venture & Family Office Investments and focused on specific regional needs like Africa, Asia, Middle East, Europe and US.  Block 2 focused on Biotech and how to scale by Building Strategic Partnerships with major industry players.

​​

Core Challenges:

  • How to navigate a global investment environment where Europe must compete with rapidly accelerating hubs in Asia and the Middle East.

  • How to integrate impact and ESG frameworks into long-term investment strategies without sacrificing returns.

  • How to build strategic industry partnerships early to improve biotech and healthcare exit outcomes (M&A, IPOs).

  • How to structure cross-border deals and collaborations in an increasingly fragmented global economy.

  • How family offices can grow their influence in direct investments while preserving governance and legacy values.

 
Key Topics Covered:

  • Comparative global investment trends (Europe, Switzerland, U.S., Asia).

  • Family offices' evolving role in direct investments and impact strategies.

  • How to align startups’ scaling needs with investors' expectations and risk models.

  • Building biotech exits through strategic partnerships with industry leaders.

  • Insights from founders and investors on successful cross-border exit strategies.

  • Investor reverse pitches sharing investment theses, exit strategies, and portfolio successes.

​​
Day 2: Investing in Emerging Technologies, Longevity, and Deeptech (18 June 2025)

Investors must quickly adapt to emerging sectors - from longevity and healthcare innovation to AI, 3D printing, quantum, next-gen materials, and blockchain - while navigating a lack of standardized valuation models, increased technical complexity, and shifting global capital flows. Identifying real, scalable breakthroughs early is essential to maintaining competitive advantage and achieving long-term returns. Exploring the impact of emerging technologies and how Artificial Intelligence is transforming sectors such as Longevity, Medtech, Diagnostics and Deeptech was the focus of Day 2 and how can we integrate these technologies and solutions in existing industries and how to find new partnership opportunities and how to identify the right investments  

​

Day 2

Investing in Emerging Technologies, Longevity, and Deeptech

Focus: Exploring the impact of emerging technologies and how Artificial Intelligence is transforming sectors such as Longevity, Medtech, and Deeptech.

  • Block 3:   Longevity and Emerging Healthcare Technologies.  The Role of Venture Capital & Family offices  in accelerating Longevity and Medtech Advancements

  • Block 4: AI, DeepTech & Frontier Technologies. How to identify the next generation of tech disruptors​​

 
Core Challenges:

  • How to evaluate and capitalize on advancements in healthcare, longevity, and medtech in a globalized context.

  • How venture and real estate investors are building the infrastructure for the emerging longevity economy.

  • How to integrate AI and frontier technologies into robust, future-ready investment strategies.

  • How to de-risk early exposure to DeepTech innovations while capturing upside potential.

  • How to collaborate across venture, family offices, and strategic capital to accelerate innovation.

 
Key Topics Covered:

  • Investment opportunities across healthcare, digital health, regenerative medicine, and longevity sectors.

  • How venture capital and real estate are converging to build longevity-driven ecosystems.

  • How emerging technologies are redefining innovation pipelines and investment strategies.

  • Strategies for sourcing, underwriting, and scaling DeepTech startups.

  • Reverse pitch sessions showcasing scalable startup innovations in digital health, biotech, medtech, and frontier technologies.

​​​Detailed agenda:
​
Day 1 (17 June 2025)
​

  • Lightning Talk: Connection between Art, Science, Innovation and Technology

​

Block 1: The Future of Venture & Family Office Investments

  • Keynote:  Demystifying the Family Office and Emerging Trends in the Field

    • Family offices play an important (and increasing) role in the direct investment space.

    • What are some of the major drivers of this trend?

    • What are the specifics of the Swiss family office landscape? Comparing Switzerland to different regions.

  • Fireside Chat: Impact investment- How to change the paradigm with ESGs and ESG ratings.

  • Panel:  "From VC to Family Office: Bridging Investment Strategy, Startup Expectations & Cross-Border Collaboration".

    • How do we balance  making the right investment decisions and understand the difference in expectations between investors and startups and how to make sure the investments generate long term impact and not only short term gain.

    • How do family offices, VCs and investors see this topic, and what is the difference between regions, Europe, vs. US, Africa, Asia , what are the learnings?

    • This experienced panel will bring in perspectives from a global view and also will share insights on how to overcome some of these challenges. 

  • Startup Pitch Session: Startups in Biotech/Digital health/Medtech

​​

Block 2: Scaling Biotech: Building Strategic Partnerships for Global Growth

Industry role as major partner for Investor Strategies & Scaling Healthcare

​

  • Keynote: “The Art of Building Success in Biotech Partnerships: Industry-Driven M&A, Exits, and IPOs" Industry leaders will discuss strategic considerations behind successful biotech exits, including mergers, acquisitions, and public offerings . The session will explore how industry partnerships can enhance exit outcomes and drive sustainable growth. Speakers will share insights into navigating cross-border challenges, leveraging strategic alliances, and positioning companies for successful exits through IPOs or acquisitions. Attendees will gain a comprehensive understanding of how investors not only provide capital but also contribute industry expertise, networks, and strategic guidance to drive biotech success.

  • Panel: “Insights from Successful Founders and Investors” Founders and investors who have successfully exited biotech ventures will share their experiences, focusing on the importance of aligning with industry partners to achieve successful outcomes. The discussion will highlight key lessons learned and strategies employed to navigate the exit process effectively.​

  • Startup Pitch Session: Startups in Biotech, and Diagnostics 

​

Day 2 (18 June 2025)
​

  • Lightning Talk:Art, Design, Science and Data: How integration shapes the Future

​

Block 3:  Longevity and Emerging Healthcare Technologies

  • Keynote: “ Exploring Emerging Investment Frontiers: Healthcare, Longevity, Medtech”

  • Panel: Capital & Concrete: How Venture Investors and Real Estate Capital Are Building the Longevity Economy ( From Medtech Labs to Clinics – Where VC, Family Offices, and Property Collide"

  • Startup Pitch Session: Startups in Digital Health, Longevity, Medtech

​​

Block 4: DeepTech & Frontier Technologies

  • Keynote: “How AI & DeepTech Are Redefining Investment Strategies”

  • Panel: “Investor Playbook: Finding the Next Big Tech Disruptor"

  • Startup Pitch Session: Startups in Deeptech (next-gen materials, 3D printing, transport, robotics, neurotech)

 
​Networking:

Networking is structured around investment alignment — offering VCs and family offices access to vetted startups, peer investors, and emerging market insights.

​

​Cocktail Apero in Courtyard of Museum

VIP Dinner

VIP Preview of VOLTA Art Fair

bottom of page